HSTO is expected to report earnings to rise 10.20% to -54 cents per share on November 09
Q3'23
Est.
$-0.54
Q2'23
Est.
$-0.49
Q1'23
Beat
by $0.59
Q4'22
Beat
by $0.41
Q3'22
Beat
by $0.48
The last earnings report on August 10 showed earnings per share of -49 cents, meeting the estimate of -49 cents. With 375.00 shares outstanding, the current market capitalization sits at 918.43K.
a company, which engages in the development of patented, innovative technologies that replace and regenerate tissues in the body for the aesthetic and therapeutic markets